Here's the official scoop on Iressa:

http://www.fda.gov/cder/consumerinfo/druginfo/iressa.htm

http://www.fda.gov/bbs/topics/news/2004/new01145.html

http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4095S2_01_03_AstraZeneca-Clinical-Relevance.ppt

http://www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4095B2_01_01-AstraZeneca-Iressa.pdf

Please note that Iressa is indicated for non small oat cell lung cancer. It's application for H&N patients is investigational and "off-label".

In some instances the patients had a slightly better survival rate with the placebo.

Gary Allsebrook
***********************************
Dx 11/22/02, SCC, 6 x 3 cm Polypoid tumor, rt tonsil, Stage III/IVA, T3N0M0 G1/2
Tx 1/28/03 - 3/19/03, Cisplatin ct x2, IMRT, bilateral, with boost, x35(69.96Gy)
________________________________________________________
"You are a mist that appears for a little while and then vanishes" (James 4:14 NIV)